An evaluation of the impact of CGRP monoclonal antibodies on the cytokine profile of the immune system in migraine

Project: Research

Project Details

Project Description

CGRP monoclonal antibodies are an effective new preventative treatment for chronic migraine, however given the multiple biological functions of CGRP, an off-target effect of its inhibition is possible. In 2021, the group published a series of possible inflammatory complications following administration of the medication. This project is designed to further explore the effect of CGRP mAbs by evaluating the cytokine profile of patients pre/post administration.
StatusActive
Effective start/end date1/02/23 → …